Searched for
GLENMARK PHARMA S
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit MishraIndian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative streng...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Ahead of Market: 10 things that will decide stock market action on WednesdayNifty 50 and BSE Sensex declined amid selling in banking, auto and IT stocks. Markets remain range-bound, awaiting triggers, with analysts ...
- Buy the dip, but avoid IT, back pharma & power, says Rudramurthy BVIndian markets are experiencing a healthy correction, according to Vachana Investments' MD, CA Rudramurthy BV. He advises waiting for speci...
- Stock Radar: Glenmark Pharma breaks out from a range to hit fresh record high in March 2026; what should investors do?Glenmark Pharma Ltd has broken out of a 7-month consolidation on weekly charts, reaching fresh record highs. Experts suggest short-term tra...
- Glenmark Pharma shares rally 14% on AbbVie boost; analysts hike targets to Rs 2,800Glenmark Pharma surged 14% after its subsidiary signed a $700 million licensing deal with AbbVie for its experimental cancer drug, ISB 2001...
- Stock Radar: Breakout from falling trendline makes Glenmark an attractive buy; check target & stop lossGlenmark Pharma Ltd has broken out of an 8-month consolidation, breaching a downward trendline. Experts suggest a buy for short-to-medium t...
- Buy Glenmark Pharma with target price of Rs 565: Prakash GabaGlenmark Pharma is a 'BUY' call with a target of Rs 565 and a stop loss of Rs 544.
- Buy Glenmark Pharma with target price of Rs 560: Prakash GabaGlenmark Pharma is a 'BUY' call with a target of Rs 560 and a stop loss of Rs 537.
- Buy Glenmark Pharma Ltd with target price of Rs 605: Mitesh ThackerGlenmark Pharma Ltd is a 'BUY' call with a target of Rs 605 and a stop loss of Rs 569.
- Buy Glenmark Pharma with target price of Rs 599: Prakash GabaGlenmark Pharma is a 'BUY' call with a target of Rs 599 and a stop loss of Rs 570.
- Buy Glenmark Pharma with target price of Rs 575: Mitesh ThackerGlenmark Pharma is a 'BUY' call with a target of Rs 575 and a stop loss of Rs 540.
- Sell Glenmark Pharma with target price of Rs 560: Ashwani GujralGlenmark Pharma Ltd is a 'SELL' call with a target of Rs 560 and a stop loss of Rs 595.
- Buy Glenmark Pharma with target price of Rs 162: Deepak MohoniBuy Glenmark Pharma at a stop of Rs 168.
- Buy Glenmark Pharma Ltd with a stop loss of Rs 460: Ashwani GujralGlenmark Pharma Ltd is a ‘BUY’ call with a target of Rs 495.
Load More
